Jr. Charles E. Phillips - 14 Oct 2022 Form 4 Insider Report for Oscar Health, Inc. (OSCR)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
18 Oct 2022, 16:14:29 UTC
Prior SEC filing
04 Oct 2022
Next SEC filing
04 Jan 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Melissa Curtin, Attorney-in-fact

Key filing fact

Jr. Charles E. Phillips filed Form 4 for Oscar Health, Inc. (OSCR) on 18 Oct 2022.

Key facts

  • This page summarizes Jr. Charles E. Phillips's Form 4 filing for Oscar Health, Inc. (OSCR).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 18 Oct 2022, 16:14.

Change

  • Previous filing in this sequence was filed on 04 Oct 2022.
  • Current net transaction value: +$23,137.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OSCR transaction Derivative

Deferred Stock Unit

Award

Transaction value
$23,137
Shares
+6,573
Change %
+138%
Price
$3.52
Shares after
11,339
Date
14 Oct 2022
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
6,573
Exercise price
Footnotes
F1, F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each deferred stock unit represents a right to receive one share of the Company's Class A common stock.

Footnote F2

The Reporting Person elected, pursuant to the Issuer's Deferred Compensation Plan for Directors, to receive deferred stock units in lieu of cash retainer payments for service on the Issuer's board of directors. The price of the deferred stock units reported herein represents the closing price of the Issuer's Class A Common Stock on October 14, 2022, which price was used to calculate the number of deferred stock units issued to the Reporting Person.

Footnote F3

The deferred stock units will be settled for cash or shares of Class A common stock, in the Issuer's discretion, within 45 days of the first to occur of (i) termination of service; (ii) a change in control; (iii) death; or (iv) disability. Deferred stock units issued in lieu of cash retainer payment are 100% vested on the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .